脑出血血肿体积对强化降压疗效的影响:四项试验汇总分析
该研究汇总INTERACT4与ATACH-2等四项急性脑出血早期强化降压试验的个体数据,共6125例有血肿体积数据者。强化降压改善功能预后(mRS不利偏移OR=0.90,95%CI 0.82–0.99,p=0.027),并降低血肿扩大风险,疗效随血肿体积呈U形曲线,约20ml处获益最大。
要点
- 急性脑出血早期强化降压可改善功能预后并减少血肿扩大。
- 血肿体积影响疗效,约7–33ml区间获益,20ml处峰值。
- 血肿体积过小或过大时强化降压获益不明显。
核心结论
- 急性脑出血早期强化降压改善功能预后并降低血肿扩大,但疗效因血肿体积而异。
研究设计与样本
- 汇总分析INTERACT4和ATACH-2等四项急性脑出血早期强化降压关键试验的个体患者数据。
- 共6125例有血肿体积数据者纳入功能预后分析,3897例有血肿扩大数据者纳入血肿扩大分析。
- 采用以试验为随机效应的广义线性混合模型,评估血肿体积的效应修饰并绘制疗效曲线。
主要发现
- 强化降压改善功能恢复,mRS不利偏移OR=0.90(95%CI 0.82–0.99,p=0.027)。
- 强化降压降低绝对血肿扩大风险,OR=0.88(95%CI 0.78–0.99,p=0.043)。
- 强化降压降低相对血肿扩大风险,OR=0.88(95%CI 0.78–0.99,p=0.034)。
- 血肿体积对功能预后和绝对血肿扩大的疗效修饰交互p值分别为0.043和0.025。
- 疗效呈U形曲线,功能预后获益区间为血肿体积7.5–27.5ml,绝对血肿扩大获益区间为7.0–32.5ml,均在20ml处峰值。
临床怎么用
- 急性脑出血早期强化降压可考虑用于改善功能预后和减少血肿扩大。
- 血肿体积约7–33ml(尤其约20ml)的患者可能获益更明显,选择患者时应考虑血肿体积。
局限性
- 本文为汇总分析,原文未报告纳入研究的具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to assess the heterogeneity in treatment effect of intensive blood pressure (BP)-lowering across hematoma volume after acute intracerebral hemorrhage (ICH). METHODS: We undertook a pooled analysis of individual patient data from the pivotal trials of early intensive BP-lowering in ICH (the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 4 [INTERACT4] and Antihypertensive Treatment of Acute Cerebral Hemorrhage 2 [ATACH-2] studies). The primary outcome was functional recovery, defined by the distribution of scores on modified Rankin scale (mRS). Secondary outcomes were hematoma expansion (HE) over 24 hours, defined by absolute (<0, 0-6, 6-12.5, and >12.5 ml) and relative HE (<0, 0-33, 33-66, and >66%). Generalized linear mixed models with trial as a random effect were conducted. We further assessed effect modification by hematoma volume and plotted the treatment effect curve. RESULTS: Among 6,125 individuals with available hematoma volume, intensive BP-lowering improved functional recovery (odds ratio [OR] for unfavorable shift in mRS score = 0.90, 95% confidence interval [CI] = 0.82 to 0.99, p = 0.027). In 3,897 participants with available HE, intensive BP-lowering reduced the risk of absolute (OR = 0.88, 95% CI = 0.78 to 0.99, p = 0.043) and relative (OR = 0.88, 95% CI = 0.78 to 0.99, p = 0.034) HE. We found effect modification of treatment on functional outcome and absolute HE by hematoma volume (p for interaction = 0.043 and 0.025, respectively). U-shaped curves were observed, with benefits seen in cases with hematoma volume of 7.5 to 27.5 and 7.0 to 32.5 ml, respectively, both peaking at 20 ml. INTERPRETATION: Early intensive BP-lowering improves functional outcome and reduces HE in ICH. Heterogeneity by hematoma volume indicates the importance of patient selection in future trials and clinical practice. ANN NEUROL 2026;100:171-179.
引用
- Ren X, Li Q, Ouyang M, et al. Effects of Blood Pressure Lowering Across Hematoma Volume in Acute Intracerebral Hemorrhage: Pooled Analysis of the Four INTERACT and ATACH-2 Trials. Ann Neurol. 2026. PMID: 41923289. doi:10.1002/ana.78216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。